Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis
Status:
Withdrawn
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy of the ophthalmic solution
PRO-118 compared with olopatadine hydrochloride ophthalmic solution in allergic
conjunctivitis.